ASSESSING THE BENEFIT OF CONTINUOUS TREATMENT IN THE FIRST TRIAL (MM-020): IMPACT OF RESPONSE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0

作者：

Bahlis, N. ^{[1
]}

Corso, A. ^{[2
]}

Muegge, L. O. ^{[3
]}

Shen, Z. X. ^{[4
]}

Desjardins, P. ^{[5
]}

Stoppa, A. M. ^{[6
]}

Decaux, O. ^{[7
]}

de Revel, T. ^{[8
]}

Granell, M. ^{[9
]}

Marit, G. ^{[10
]}

Nahi, H. ^{[11
]}

Demuynck, H. ^{[12
]}

Huang, S. Y. ^{[13
]}

Basu, S. ^{[14
]}

Ervin-Haynes, A. ^{[15
]}

Leupin, N. ^{[15
]}

Marek, J. ^{[15
]}

Chen, G. ^{[15
]}

Facon, T. ^{[16
]}

机构：

[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada

[2] Policlin San Mateo Univ Pavia, Pavia, Italy

[3] Univ Klinikum Jena, Klink Inner Med 2, Jena, Germany

[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China

[5] Hop Charles Lemoyne, Longueuil, PQ, Canada

[6] Inst J Paoli I Calmettes, F-13009 Marseille, France

[7] CHRU Hosp Sod Med Interne, Rennes, France

[8] Hop Instruct Armees Percy, Paris, France

[9] Hosp Santa Cree & St Pau, Barcelona, Spain

[10] CHU Bordeaux Hop Haut Leveque, Pessac, France

[11] Karolinska Univ, Huddinge Hosp, Solana, Sweden

[12] Jan Yperman Hosp VZW, Leper, Belgium

[13] Natl Taiwan Univ Hosp, Taipei, Taiwan

[14] New Cross Hosp, Wolverhampton, W Midlands, England

[15] Celgene Corp, Summit, NJ USA

[16] Hop Claude Huriez, Serv Malad Sang, Lille, France

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P277

引用

页码：85 / 86

页数：2

共 50 条

[21] Initial treatment of transplant-ineligible patients in multiple myeloma
Mateos, Maria-Victoria
Leleu, Xavier
Palumbo, Antonio
San Miguel, Jesus-F
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 67 - 77
[22] Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients
Belch, Andrew
Bahlis, Nizar
White, Darrell
Cheung, Matthew
Chen, Christine
Shustik, Chaim
Song, Kevin
Tosikyan, Axel
Dispenzieri, Angela
Anderson, Kenneth
Brown, Diane
Robinson, Suzanne
Srinivasan, Shankar
Facon, Thierry
CANCER MEDICINE, 2020, 9 (23): : 8923 - 8930
[23] CONTINUOUS LENALIDOMIDE TREATMENT FOR TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: UPDATE ON PATIENTS AGED 65-75 YEARS ENROLLED IN MM-015
Palumbo, A.
Hajek, R.
Kropff, M.
Petrucci, M. T.
Catalano, J.
Delforge, M.
Adam, Z.
Foa, R.
Yu, Z.
Herbein, L.
Jacques, C.
Dimopoulos, M.
HAEMATOLOGICA, 2012, 97 : 341 - 342
[24] Daratumumab: A Review in Combination Therapy for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Syed, Yahiya Y.
DRUGS, 2019, 79 (04) : 447 - 454
[25] Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews
Visacri, Manlia Berlofa
Ribeiro, Mayra Carvalho
Komoda, Denis Satoshi
Duarte, Bruno Kosa Lino
Correa, Carlos Roberto Silveira
Maia, Flavia de Oliveira Motta
Alves, Daniela Fernanda dos Santos
VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
[26] Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma
Facon, Thierry
Lee, Jae Hoon
Moreau, Philippe
Niesvizky, Ruben
Dimopoulos, Meletios
Hajek, Roman
Pour, Ludek
Jurczyszyn, Artur
Qiu, Lugui
Klippel, Zandra
Zahlten-Kumeli, Anita
Osman, Muhtarjan
Paiva, Bruno
San-Miguel, Jesus
BLOOD, 2019, 133 (18) : 1953 - 1963
[27] Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma
Wang, Junzhe
Song, Xiaoning
Zhang, Xian
Liu, Han
Zang, Meirong
Qi, Dianwen
Zhang, Jinqiao
Sun, Lixia
ANNALS OF HEMATOLOGY, 2024, 103 (03) : 917 - 933
[28] Phase 3 FIRST Trial in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Subgroup Analysis of Patients From Canada and the United States
Belch, Andrew
Bahlis, Nizar J.
White, Darrell
Cheung, Matthew
Chen, Christine
Shustik, Chaim
Song, Kevin
Tosikyan, Axel
Dispenzieri, Angela
Anderson, Kenneth C.
Kotey, Stanley
Brown, Diane
Robinson, Suzanne
Srinivasan, Shankar
Facon, Thierry
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E225 - E225
[29] Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients
Rafae, Abdul
Ehsan, Hamid
Wahab, Ahsan
Khan, Sana Irfan
Khan, Israr
Ashraf, Sara
Ali, Sundas
Khalid, Farhan
Neupane, Karun
Valent, Jason
Khouri, Jack
Samaras, Christy
Mazzoni, Sandra
Anwer, Faiz
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
[30] Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma
Junzhe Wang
Xiaoning Song
Xian Zhang
Han Liu
Meirong Zang
Dianwen Qi
Jinqiao Zhang
Lixia Sun
Annals of Hematology, 2024, 103 : 1411 - 1414

← 1 2 3 4 5 →